Results 71 to 80 of about 19,799 (306)

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

The Arrow of Time in Cosmology [PDF]

open access: yes, 2002
Scientific cosmology is an empirical discipline whose objects of study are the large-scale properties of the universe. In this context, it is usual to call the direction of the expansion of the universe the "cosmological arrow of time". However, there is
Castagnino, Mario   +2 more
core  

Imprints of Primordial Non-Gaussianity on Large Scale Structure in the Universe [PDF]

open access: yes, 2016
Philosophiae Doctor - PhDLarge scale structure in the universe is one of the most important probing tools for cosmological modelling. Assuming the hot big bang model of the universe, the expansion history has undergone two phases of acceleration.
Hashim, Mahmoud Yousif Ali Wahba
core   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Inflationary Imprints on the Large Scale Structure of the Universe

open access: yes, 2022
Inflation is the predominant model describing the early universe, however we do not know much about the underlying theory, besides, there are other open questions in cosmology, for example about the nature of dark matter and dark energy.
Tranquilli, Nicola
core  

Evolution of Multifractal Structure in the Large-scale Structure in the Universe [PDF]

open access: yes, 2014
We have analyzed the evolution of multifractal structure in the Universe. The galaxies construct large-scale structure in the Universe. According to recent observations, the large-scale structure have multifractal structure during several h−1Mpc.
立川, 崇之
core   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Large Scale Structure Of The Universe

open access: yes, 2007
How is the universe organized on large scales? How did this structure evolve from the unknown initial conditions of a rather smooth early universe to the present time? The answers to these questions will shed light on the cosmology we live in, the amount,
Neta Bahcall
core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy